Terms: = Bone cancer AND BCL11A, BCL11A-L, 53335, ENSG00000119866, FLJ34997, CTIP1, BCL11A-S, BCL11A-XL, KIAA1809, Q9H165, EVI9, FLJ10173
17 results:
1. Hurdles to the Adoption of Gene Therapy as a Curative Option for Transfusion-Dependent Thalassemia.
Thuret I; Ruggeri A; Angelucci E; Chabannon C
Stem Cells Transl Med; 2022 Apr; 11(4):407-414. PubMed ID: 35267028
[TBL] [Abstract] [Full Text] [Related]
2. Molecular and cellular mechanisms that regulate human erythropoiesis.
Caulier AL; Sankaran VG
Blood; 2022 Apr; 139(16):2450-2459. PubMed ID: 34936695
[TBL] [Abstract] [Full Text] [Related]
3. bcl11a promotes myeloid leukemogenesis by repressing PU.1 target genes.
Sunami Y; Yokoyama T; Yoshino S; Takahara T; Yamazaki Y; Harada H; Nakamura T
Blood Adv; 2022 Mar; 6(6):1827-1843. PubMed ID: 34714913
[TBL] [Abstract] [Full Text] [Related]
4. A polygenic score for acute vaso-occlusive pain in pediatric sickle cell disease.
Rampersaud E; Kang G; Palmer LE; Rashkin SR; Wang S; Bi W; Alberts NM; Anghelescu D; Barton M; Birch K; Boulos N; Brandow AM; Brooke RJ; Chang TC; Chen W; Cheng Y; Ding J; Easton J; Hodges JR; Kanne CK; Levy S; Mulder H; Patel AP; Puri L; Rosencrance C; Rusch M; Sapkota Y; Sioson E; Sharma A; Tang X; Thrasher A; Wang W; Yao Y; Yasui Y; Yergeau D; Hankins JS; Sheehan VA; Downing JR; Estepp JH; Zhang J; DeBaun M; Wu G; Weiss MJ
Blood Adv; 2021 Jul; 5(14):2839-2851. PubMed ID: 34283174
[TBL] [Abstract] [Full Text] [Related]
5. CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.
Frangoul H; Altshuler D; Cappellini MD; Chen YS; Domm J; Eustace BK; Foell J; de la Fuente J; Grupp S; Handgretinger R; Ho TW; Kattamis A; Kernytsky A; Lekstrom-Himes J; Li AM; Locatelli F; Mapara MY; de Montalembert M; Rondelli D; Sharma A; Sheth S; Soni S; Steinberg MH; Wall D; Yen A; Corbacioglu S
N Engl J Med; 2021 Jan; 384(3):252-260. PubMed ID: 33283989
[TBL] [Abstract] [Full Text] [Related]
6. bcl11a enhancer-edited hematopoietic stem cells persist in rhesus monkeys without toxicity.
Demirci S; Zeng J; Wu Y; Uchida N; Shen AH; Pellin D; Gamer J; Yapundich M; Drysdale C; Bonanno J; Bonifacino AC; Krouse AE; Linde NS; Engels T; Donahue RE; Haro-Mora JJ; Leonard A; Nassehi T; Luk K; Porter SN; Lazzarotto CR; Tsai SQ; Weiss MJ; Pruett-Miller SM; Wolfe SA; Bauer DE; Tisdale JF
J Clin Invest; 2020 Dec; 130(12):6677-6687. PubMed ID: 32897878
[TBL] [Abstract] [Full Text] [Related]
7. Genome editing of HBG1 and HBG2 to induce fetal hemoglobin.
Métais JY; Doerfler PA; Mayuranathan T; Bauer DE; Fowler SC; Hsieh MM; Katta V; Keriwala S; Lazzarotto CR; Luk K; Neel MD; Perry SS; Peters ST; Porter SN; Ryu BY; Sharma A; Shea D; Tisdale JF; Uchida N; Wolfe SA; Woodard KJ; Wu Y; Yao Y; Zeng J; Pruett-Miller S; Tsai SQ; Weiss MJ
Blood Adv; 2019 Nov; 3(21):3379-3392. PubMed ID: 31698466
[TBL] [Abstract] [Full Text] [Related]
8. Hemoglobin genetics: recent contributions of GWAS and gene editing.
Smith EC; Orkin SH
Hum Mol Genet; 2016 Oct; 25(R2):R99-R105. PubMed ID: 27340226
[TBL] [Abstract] [Full Text] [Related]
9. Mathematical modeling of erythrocyte chimerism informs genetic intervention strategies for sickle cell disease.
Altrock PM; Brendel C; Renella R; Orkin SH; Williams DA; Michor F
Am J Hematol; 2016 Sep; 91(9):931-7. PubMed ID: 27299299
[TBL] [Abstract] [Full Text] [Related]
10. bcl11a expression in acute phase chronic myeloid leukemia.
Yin J; Zhang F; Tao H; Ma X; Su G; Xie X; Xu Z; Zheng Y; Liu H; He C; Mao ZJ; Wang Z; Chang W; Gale RP; Wu D; Yin B
Leuk Res; 2016 Aug; 47():88-92. PubMed ID: 27285855
[TBL] [Abstract] [Full Text] [Related]
11. bcl11a expression in acute myeloid leukemia.
Tao H; Ma X; Su G; Yin J; Xie X; Hu C; Chen Z; Tan D; Xu Z; Zheng Y; Liu H; He C; Mao ZJ; Yin H; Wang Z; Chang W; Gale RP; Chen Z; Wu D; Yin B
Leuk Res; 2016 Feb; 41():71-5. PubMed ID: 26707798
[TBL] [Abstract] [Full Text] [Related]
12. Reverse-phase protein array for prediction of patients at low risk of developing bone metastasis from breast cancer.
Hayashi N; Manyam GC; Gonzalez-Angulo AM; Niikura N; Yamauchi H; Nakamura S; Hortobágyi GN; Baggerly KA; Ueno NT
Oncologist; 2014 Sep; 19(9):909-14. PubMed ID: 25117064
[TBL] [Abstract] [Full Text] [Related]
13. Genetic regulation of fetal haemoglobin in inherited bone marrow failure syndromes.
Alter BP; Rosenberg PS; Day T; Menzel S; Giri N; Savage SA; Thein SL
Br J Haematol; 2013 Aug; 162(4):542-6. PubMed ID: 23713742
[TBL] [Abstract] [Full Text] [Related]
14. Post-transplant lymphoproliferative disease of donor origin, following haematopoietic stem cell transplantation in a patient with blastic plasmacytoid dendritic cell neoplasm.
Piccin A; Morello E; Svaldi M; Haferlach T; Facchetti F; Negri G; Vecchiato C; Fisogni S; Pusceddu I; Cortelazzo S
Hematol Oncol; 2012 Dec; 30(4):210-3. PubMed ID: 22915052
[TBL] [Abstract] [Full Text] [Related]
15. Chronic lymphocytic leukemia With t(2;14)(p16;q32) involves the bcl11a and IgH genes and is associated with atypical morphologic features and unmutated IgVH genes.
Yin CC; Lin KI; Ketterling RP; Knudson RA; Medeiros LJ; Barron LL; Huh YO; Luthra R; Keating MJ; Abruzzo LV
Am J Clin Pathol; 2009 May; 131(5):663-70. PubMed ID: 19369625
[TBL] [Abstract] [Full Text] [Related]
16. A retroviral mutagenesis screen reveals strong cooperation between bcl11a overexpression and loss of the Nf1 tumor suppressor gene.
Yin B; Delwel R; Valk PJ; Wallace MR; Loh ML; Shannon KM; Largaespada DA
Blood; 2009 Jan; 113(5):1075-85. PubMed ID: 18948576
[TBL] [Abstract] [Full Text] [Related]
17. Characterization of early stages of human B cell development by gene expression profiling.
Hystad ME; Myklebust JH; Bø TH; Sivertsen EA; Rian E; Forfang L; Munthe E; Rosenwald A; Chiorazzi M; Jonassen I; Staudt LM; Smeland EB
J Immunol; 2007 Sep; 179(6):3662-71. PubMed ID: 17785802
[TBL] [Abstract] [Full Text] [Related]
